
Medtronic plc ownership: holders and insider trading
$102.86+1.85%Close 13 Nov 2026 · Market value $132.0B · Next results 24 Nov 2026
As filed, its directors and officers own 0.3% of the shares (proxy statement, 5 Aug 2026); 2,107 institutional managers reported holding 86.3% at 30 Jun 2026. Over the last twelve months, insiders sold $14.67M of shares on the open market, $6.01M of it under 10b5-1 plans set in advance, and bought none.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| The Vanguard Group | Holder | 117M | 9.12% | Proxy statement | 5 Aug 2026 |
|---|
| BlackRock, Inc. | Holder | 112M | 8.72% | Proxy statement | 5 Aug 2026 |
|---|
| Vanguard Capital Management | Holder | 96.4M | 7.51% | Schedule 13G | 31 Mar 2026 |
|---|
| State Street | Institution | 66.1M | 5.2% | Schedule 13G | 30 Sep 2026 |
|---|
| Geode Capital Management | Institution | 30.2M | 2.36%* | Form 13F | 30 Jun 2026 |
|---|
| JPMorgan Chase | Institution | 27.8M | 2.17%* | Form 13F | 30 Jun 2026 |
|---|
| First Eagle Investment Management, LLC | Institution | 27.6M | 2.15%* | Form 13F | 30 Jun 2026 |
|---|
| Capital Group | Institution | 21.6M | 1.69%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 21.3M | 1.67%* | Form 13F | 30 Jun 2026 |
|---|
| Massachusetts Financial Services Co | Institution | 19.9M | 1.55%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 19.4M | 1.52%* | Form 13F | 30 Jun 2026 |
|---|
| Deutsche Bank | Institution | 18.4M | 1.44%* | Form 13F | 30 Jun 2026 |
|---|
| Invesco | Institution | 17.9M | 1.40%* | Form 13F | 30 Jun 2026 |
|---|
| Franklin Templeton | Institution | 17.6M | 1.37%* | Form 13F | 30 Jun 2026 |
|---|
| Norges Bank | Institution | 16.6M | 1.29%* | Form 13F | 30 Jun 2026 |
|---|
| Royal Bank of Canada | Institution | 16.0M | 1.25%* | Form 13F | 30 Jun 2026 |
|---|
| BNY | Institution | 14.7M | 1.15%* | Form 13F | 30 Jun 2026 |
|---|
| Arrowstreet Capital, Limited Partnership | Institution | 12.9M | 1.01%* | Form 13F | 30 Jun 2026 |
|---|
| Northern Trust | Institution | 11.6M | 0.91%* | Form 13F | 30 Jun 2026 |
|---|
| Ameriprise | Institution | 11.6M | 0.90%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Marinaro Michael · President | 2 Nov 2026 | Grant or award | +6.5K | — | — |
|---|
| Marinaro Michael · EVP, Pres MedSurg and Americas | 15 Oct 2026 | Open-market sale (10b5-1 plan) | −10.4K | $96.00 | $1.00M |
|---|
| Martha Geoffrey · Chairman and CEO · Director | 15 Oct 2026 | Open-market sale (10b5-1 plan) | −50.0K | $95.00 | $4.75M |
|---|
| KIIL HARRY SKIP · EVP & President Cardiovascular | 16 Sep 2026 | Open-market sale | −1.5K | $93.65 | $138.9K |
|---|
| Marinaro Michael · EVP, Pres MedSurg and Americas | 20 Aug 2026 | Shares withheld for tax | −1.1K | $92.30 | $100.1K |
|---|
| Thompson Kweli · EVP & President, Neuroscience | 3 Aug 2026 | Grant or award | +6.9K | — | — |
|---|
| Blomquist Denise L. · Chief Accounting Officer | 3 Aug 2026 | Grant or award | +2.3K | — | — |
|---|
| Pieton Thierry · EVP & Chief Financial Officer | 3 Aug 2026 | Grant or award | +11.5K | — | — |
|---|
| Walter Matthew R. · SVP, Chief HR Officer | 3 Aug 2026 | Grant or award | +5.8K | — | — |
|---|
| Marinaro Michael · EVP, Pres MedSurg and Americas | 3 Aug 2026 | Grant or award | +46.1K | — | — |
|---|
| Marinaro Michael · EVP, Pres MedSurg and Americas | 3 Aug 2026 | Grant or award | +11.0K | — | — |
|---|
| Quinn Michelle · EVP, GC and Secretary | 3 Aug 2026 | Grant or award | +6.3K | — | — |
|---|
| KIIL HARRY SKIP · EVP & President Cardiovascular | 3 Aug 2026 | Grant or award | +9.2K | — | — |
|---|
| Martha Geoffrey · Chairman and CEO · Director | 3 Aug 2026 | Grant or award | +41.5K | — | — |
|---|
| Thompson Kweli · EVP & President, Neuroscience | 31 Jul 2026 | Shares withheld for tax | −1.7K | $85.39 | $148.5K |
|---|
| Blomquist Denise L. · Chief Accounting Officer | 31 Jul 2026 | Shares withheld for tax | −212 | $85.39 | $18.10K |
|---|
| Walter Matthew R. · SVP, Chief HR Officer | 31 Jul 2026 | Shares withheld for tax | −1.7K | $85.39 | $143.0K |
|---|
| Marinaro Michael · EVP, Pres MedSurg and Americas | 31 Jul 2026 | Shares withheld for tax | −3.4K | $85.39 | $286.6K |
|---|
| KIIL HARRY SKIP · EVP & President Cardiovascular | 31 Jul 2026 | Shares withheld for tax | −3.1K | $85.39 | $262.5K |
|---|
| Martha Geoffrey · Chairman and CEO · Director | 31 Jul 2026 | Shares withheld for tax | −15.8K | $85.39 | $1.35M |
|---|
| Quinn Michelle · EVP, GC and Secretary | 28 Jul 2026 | Shares withheld for tax | −2.1K | $86.88 | $179.8K |
|---|
| Walter Matthew R. · SVP, Chief HR Officer | 8 Jul 2026 | Open-market sale (10b5-1 plan) | −3.1K | $83.15 | $257.9K |
|---|
| KIIL HARRY SKIP · EVP & President Cardiovascular | 8 Jun 2026 | Open-market sale | −228 | $80.45 | $18.34K |
|---|
| KIIL HARRY SKIP · EVP & President Cardiovascular | 8 Jun 2026 | Open-market sale | −4.0K | $80.44 | $318.6K |
|---|
| Blomquist Denise L. · Chief Accounting Officer | 5 Jun 2026 | Shares withheld for tax | −237 | $83.32 | $19.75K |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
MDT in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.